BioMarin Pharmaceutical Q1 2025 Update
Ticker: BMRN · Form: 10-Q · Filed: May 2, 2025 · CIK: 1048477
| Field | Detail |
|---|---|
| Company | Biomarin Pharmaceutical INC (BMRN) |
| Form Type | 10-Q |
| Filed Date | May 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: pharmaceutical, earnings, 10-Q
Related Tickers: BMRN
TL;DR
BMRN Q1 2025 earnings are in, check the numbers for rare disease drug performance.
AI Summary
BioMarin Pharmaceutical Inc. reported its first quarter 2025 results, ending March 31, 2025. The company's financial performance for the period is detailed in this 10-Q filing. Specific revenue figures, net income, and operational highlights for Q1 2025 are presented, alongside comparative data from Q1 2024.
Why It Matters
This filing provides investors with the latest financial and operational performance of BioMarin Pharmaceutical, crucial for understanding the company's trajectory in the rare disease drug market.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, BioMarin faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End (End of the first quarter of 2025)
- 2024-03-31 — Prior Year Period End (End of the first quarter of 2024 for comparison)
- 2024-12-31 — Prior Year End (End of the fiscal year 2024)
Key Players & Entities
- BIOMARIN PHARMACEUTICAL INC (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250502 (date) — Filing Date
- NOVATO (location) — Company Headquarters City
- 4155066700 (phone_number) — Company Business Phone
FAQ
What were BioMarin's total revenues for the first quarter of 2025?
The filing indicates revenue data for the period ending March 31, 2025, and compares it to the period ending March 31, 2024, but specific dollar amounts for total revenue are not directly extracted in this header information.
What is BioMarin's primary industry classification?
BioMarin Pharmaceutical Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
When is BioMarin's fiscal year end?
BioMarin's fiscal year ends on December 31.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 2, 2025.
Where is BioMarin Pharmaceutical Inc. headquartered?
BioMarin Pharmaceutical Inc. is headquartered in Novato, California.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 2, 2025 regarding BIOMARIN PHARMACEUTICAL INC (BMRN).